GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 116 filers reported holding GOSSAMER BIO INC in Q2 2021. The put-call ratio across all filers is 7.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,568 | -97.1% | 13,891 | -95.8% | 0.00% | – |
| Q2 2023 | $398,081 | -75.5% | 331,734 | -74.3% | 0.00% | -100.0% |
| Q1 2023 | $1,626,841 | +693.6% | 1,291,144 | +1266.7% | 0.00% | – |
| Q4 2022 | $205,004 | -88.2% | 94,472 | -34.8% | 0.00% | -100.0% |
| Q3 2022 | $1,735,000 | +116.6% | 144,891 | +51.4% | 0.00% | – |
| Q2 2022 | $801,000 | +191.3% | 95,697 | +202.0% | 0.00% | – |
| Q1 2022 | $275,000 | -13.2% | 31,691 | +13.3% | 0.00% | – |
| Q4 2021 | $317,000 | -47.4% | 27,965 | -41.7% | 0.00% | – |
| Q3 2021 | $603,000 | +267.7% | 48,001 | +137.4% | 0.00% | – |
| Q2 2021 | $164,000 | -47.8% | 20,217 | -37.8% | 0.00% | – |
| Q4 2020 | $314,000 | -54.9% | 32,485 | -42.2% | 0.00% | – |
| Q3 2020 | $697,000 | +16.0% | 56,190 | +21.6% | 0.00% | – |
| Q2 2020 | $601,000 | – | 46,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |